tiprankstipranks
Trending News
More News >
Fisher & Paykel Healthcare Corporation Limited (FSPKF)
OTHER OTC:FSPKF

Fisher & Paykel Healthcare Corporation Limited (FSPKF) Stock Statistics & Valuation Metrics

Compare
53 Followers

Total Valuation

Fisher & Paykel Healthcare Corporation Limited has a market cap or net worth of $12.11B. The enterprise value is $13.05B.
Market Cap$12.11B
Enterprise Value$13.05B

Share Statistics

Fisher & Paykel Healthcare Corporation Limited has 586,256,650 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding586,256,650
Owned by Insiders0.22%
Owned by Institutions

Financial Efficiency

Fisher & Paykel Healthcare Corporation Limited’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 7.18%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)7.18%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee251.95K
Profits Per Employee19.00K
Employee Count6,978
Asset Turnover0.77
Inventory Turnover2.18

Valuation Ratios

The current PE Ratio of Fisher & Paykel Healthcare Corporation Limited is 113.52. Fisher & Paykel Healthcare Corporation Limited’s PEG ratio is -2.44.
PE Ratio113.52
PS Ratio0.00
PB Ratio8.56
Price to Fair Value8.56
Price to FCF166.14
Price to Operating Cash Flow35.04
PEG Ratio-2.44

Income Statement

In the last 12 months, Fisher & Paykel Healthcare Corporation Limited had revenue of 1.76B and earned 132.60M in profits. Earnings per share was 0.23.
Revenue1.76B
Gross Profit1.06B
Operating Income254.40M
Pretax Income235.70M
Net Income132.60M
EBITDA368.20M
Earnings Per Share (EPS)0.23

Cash Flow

In the last 12 months, operating cash flow was 506.10M and capital expenditures -92.50M, giving a free cash flow of 413.60M billion.
Operating Cash Flow506.10M
Free Cash Flow413.60M
Free Cash Flow per Share0.71

Dividends & Yields

Fisher & Paykel Healthcare Corporation Limited pays an annual dividend of $0.296, resulting in a dividend yield of 1.64%
Dividend Per Share$0.296
Dividend Yield1.64%
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.81
52-Week Price Change11.21%
50-Day Moving Average17.81
200-Day Moving Average21.09
Relative Strength Index (RSI)53.50
Average Volume (3m)359.00

Important Dates

Fisher & Paykel Healthcare Corporation Limited upcoming earnings date is May 27, 2025, TBA Not Confirmed.
Last Earnings DateNov 27, 2024
Next Earnings DateMay 27, 2025
Ex-Dividend DateDec 05, 2024

Financial Position

Fisher & Paykel Healthcare Corporation Limited as a current ratio of 1.83, with Debt / Equity ratio of 7.82%
Current Ratio1.83
Quick Ratio1.00
Debt to Market Cap<0.01
Net Debt to EBITDA0.29
Interest Coverage Ratio13.98

Taxes

In the past 12 months, Fisher & Paykel Healthcare Corporation Limited has paid 103.10M in taxes.
Income Tax103.10M
Effective Tax Rate0.44

Enterprise Valuation

Fisher & Paykel Healthcare Corporation Limited EV to EBITDA ratio is 41.17, with an EV/FCF ratio of 167.33.
EV to Sales8.62
EV to EBITDA41.17
EV to Free Cash Flow167.33
EV to Operating Cash Flow35.29

Balance Sheet

Fisher & Paykel Healthcare Corporation Limited has $116.60M in cash and marketable securities with $109.31M in debt, giving a net cash position of $34.30M billion.
Cash & Marketable Securities$116.60M
Total Debt$109.31M
Net Cash$34.30M
Net Cash Per Share$0.06
Tangible Book Value Per Share$2.85

Margins

Gross margin is 60.68%, with operating margin of 14.47%, and net profit margin of 7.54%.
Gross Margin60.68%
Operating Margin14.47%
Pretax Margin13.41%
Net Profit Margin7.54%
EBITDA Margin20.94%
EBIT Margin14.44%

Analyst Forecast

The average price target for Fisher & Paykel Healthcare Corporation Limited is $24.12, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$24.12
Price Target Upside31.37% Upside
Analyst ConsensusModerate Buy
Analyst Count6
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis